Abstract
We sequenced all protein-coding regions of the genome (the "exome") in two family members with combined hypolipidemia, marked by extremely low plasma levels of low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides. These two participants were compound heterozygotes for two distinct nonsense mutations in ANGPTL3 (encoding the angiopoietin-like 3 protein). ANGPTL3 has been reported to inhibit lipoprotein lipase and endothelial lipase, thereby increasing plasma triglyceride and HDL cholesterol levels in rodents. Our finding of ANGPTL3 mutations highlights a role for the gene in LDL cholesterol metabolism in humans and shows the usefulness of exome sequencing for identification of novel genetic causes of inherited disorders. (Funded by the National Human Genome Research Institute and others.).
MeSH Terms
Angiopoietin-Like Protein 3
Angiopoietin-like Proteins
Angiopoietins/genetics
Cholesterol, HDL/blood,genetics
Cholesterol, LDL/blood,genetics
Codon, Nonsense
DNA Mutational Analysis
Female
Genetic Linkage
Humans
Hypobetalipoproteinemias/genetics
Male
Pedigree
Chemicals
ANGPTL3 protein, human
Angiopoietin-Like Protein 3
Angiopoietin-like Proteins
Angiopoietins
Cholesterol, HDL
Cholesterol, LDL
Codon, Nonsense
Authors & Affiliations
27 authors, click to expand affiliations / ORCID
Musunuru Kiran
Cardiovascular Research Center, Massachusetts General Hospital, and Department of Medicine, Boston University School of Public Health, Boston, MA 02114, USA.
Pirruccello James P
Do Ron
Peloso Gina M
Guiducci Candace
Sougnez Carrie
Garimella Kiran V
Fisher Sheila
Abreu Justin
Barry Andrew J
Fennell Tim
Banks Eric
Ambrogio Lauren
Cibulskis Kristian
Kernytsky Andrew
Gonzalez Elena
Rudzicz Nicholas
Engert James C
DePristo Mark A
Daly Mark J
Cohen Jonathan C
Hobbs Helen H
Altshuler David
Schonfeld Gustav
Gabriel Stacey B
Yue Pin
Kathiresan Sekar
References (22)
22 references, click to expand
-
Absence of fatty liver in familial hypobetalipoproteinemia linked to chromosome 3p21.
Metabolism. 2005 May;54(5):682-8
PMID: 15877300
-
Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans.
J Clin Invest. 2009 Jan;119(1):70-9
PMID: 19075393
-
Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing.
Nat Biotechnol. 2009 Feb;27(2):182-9
PMID: 19182786
-
Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL).
J Biol Chem. 2009 May 15;284(20):13735-13745
PMID: 19318355
-
Biological, clinical and population relevance of 95 loci for blood lipids.
Nature. 2010 Aug 5;466(7307):707-13
PMID: 20686565
-
Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis.
J Lipid Res. 2003 Mar;44(3):470-8
PMID: 12562873
-
Exome sequencing identifies the cause of a mendelian disorder.
Nat Genet. 2010 Jan;42(1):30-5
PMID: 19915526
-
Evidence for a quantitative trait locus affecting low levels of apolipoprotein B and low density lipoprotein on chromosome 10 in Caucasian families.
J Lipid Res. 2007 Dec;48(12):2632-9
PMID: 17890784
-
Genetic diagnosis by whole exome capture and massively parallel DNA sequencing.
Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19096-101
PMID: 19861545
-
Linkage of a gene for familial hypobetalipoproteinemia to chromosome 3p21.1-22.
Am J Hum Genet. 2000 May;66(5):1699-704
PMID: 10762553
-
Targeted capture and massively parallel sequencing of 12 human exomes.
Nature. 2009 Sep 10;461(7261):272-6
PMID: 19684571
-
Hepatic proprotein convertases modulate HDL metabolism.
Cell Metab. 2007 Aug;6(2):129-36
PMID: 17681148
-
Familial hypobetalipoproteinemia: genetics and metabolism.
Cell Mol Life Sci. 2005 Jun;62(12):1372-8
PMID: 15818469
-
Genetic heterogeneity in familial hypobetalipoproteinemia: linkage and non-linkage to the apoB gene in Caucasian families.
Am J Med Genet. 1998 Feb 26;76(1):79-86
PMID: 9508071
-
ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase.
J Biol Chem. 2002 Sep 13;277(37):33742-8
PMID: 12097324
-
In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene.
Arterioscler Thromb Vasc Biol. 2000 May;20(5):1309-15
PMID: 10807747
-
A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice.
J Lipid Res. 2003 Jun;44(6):1216-23
PMID: 12671033
-
Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism.
Endocrinology. 2005 Nov;146(11):4943-50
PMID: 16081640
-
Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B.
Gastroenterology. 1996 Oct;111(4):1125-33
PMID: 8831609
-
Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism.
Crit Rev Clin Lab Sci. 2005;42(5-6):515-45
PMID: 16390683
-
Angptl3 regulates lipid metabolism in mice.
Nat Genet. 2002 Feb;30(2):151-7
PMID: 11788823
-
Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase.
Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):366-72
PMID: 17110602